Pulsed Field Ablation (PFA) is a revolutionary treatment for atrial fibrillation (AF). Affecting 1.5 million people in the UK, atrial fibrillation can cause debilitating palpitations, breathlessness, and lethargy, as well as being the cause of 1 in 5 strokes.

Traditional ablation treatments use heat or freezing to create scar patterns in the heart, reducing abnormal rhythms. However, they are time consuming and remain associated with a risk of dangerous complications caused by inadvertent damage to surrounding anatomical structures.

Pulsed Field Ablation (PFA), delivered through the Farapulse system, is a breakthrough non-thermal innovation that uses a pulsed electrical field to target only heart cells, improving safety and effectiveness. This reduces risks of complications while also making recovery faster and less painful for patients.

PFA also increases efficiency by allowing the hospital to perform three ablations per day instead of two—reducing waiting lists and enhancing patient access. By introducing this cutting-edge technology, the hospital would become the first district general hospital in the UK to offer it and cement their position as a leader in heart rhythm treatment.